Company intelligence / Profile preview

EyeKare

Beijing, Beijing, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

EyeKare is a medical artificial intelligence company specializing in the early screening and management of eye diseases. The company utilizes deep learning and big data to provide automated analysis of fundus images, targeting conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Their platform is designed to assist clinicians in large-scale screenings, particularly in primary care settings, to prevent vision loss through early detection. EyeKare's technology integrates into clinical workflows, offering high-accuracy diagnostic support and improving patient outcomes in ophthalmology.

Therapeutic areas: CardiovascularOphthalmology
Modalities: DeviceSoftware as a Medical Device
Industry: Digital Health Medical Devices

Partnerships

BaiduAier Eye Hospital GroupPeking University

Beyond the preview

Go deeper on EyeKare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EyeKare.

Explore the full profile